The International Wound Journal has a strategic partnership with several companies. These are companies who provide strategic guidance to ensure it meets the needs of our readers. In addition, our strategic partners provide a financial commitment in the form of guaranteed advertising and subscriptions to aid the development and dissemination of the journal. Our strategic partners are:
Kinetic Concepts, Inc. (KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. KCI's three primary businesses include: Advanced Wound Care, Regenerative Medicine Therapeutic Support Systems.
3M is a global supplier of single-use medical supplies to simplify and improve skin health and the treatment of wounds. Our extensive line of trusted products include skin care products, advanced wound care dressings, bandaging and compression, surgical tape and dressings, and I.V. dressings. With specific expertise in skin and wound care, we provide products, services and solutions for medical professionals in hospitals and community settings.
Systagenix Wound Management is committed to providing innovative products and services that provide breakthrough clinical and economic outcomes in the treatment of chronic and surgical wounds and the control of bleeding.
At Systagenix Wound Management we connect our heritage of trust and innovation with our focused commitment to developing wound care solutions based on evidence. We offer a full line of products and an integrated approach to treatment in the field of wound care, including products that actively promote wound healing, control bacteria and help maintain a moist wound healing environment.
By continually enhancing our product line, it is our enduring mission to bring solutions that help heal your patient.
With around 700 employees worldwide and a production facility in Gargrave, North Yorkshire, UK, Systagenix distributes products and services to more than a hundred countries.
A State of the Art technology centre, located within our production facility, accommodates an internationally recognized research and development team. Their experience and know-how in the field of wound healing continue to aid development of new innovative treatments that will enable the health care professional to heal their patients.
If you're interested in finding out more about how to become a strategic partner please contact email@example.com